MAGNITUDE CLINICAL TRIAL
DEAD

Serial Number

97830256

Owner

Intellia Therapeutics, Inc.

Attorney

Jonathan M. Gelchinsky

Filing Date

Mar 9, 2023

Add to watchlist:

No watchlists yet
View on USPTO

MAGNITUDE CLINICAL TRIAL Trademark

Serial Number: 97830256

MAGNITUDE CLINICAL TRIAL is a trademark filed by Intellia Therapeutics, Inc. on March 9, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Intellia Therapeutics, Inc. (18 trademarks)

40 Erie Street
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

March 9, 2023

Registration Date

Not Registered

Published for Opposition

April 30, 2024

Goods & Services

Organizing and recruiting patients for clinical trials for the treatment of transthyretin (ATTR) amyloidosis using in vivo gene editing technology

Medical treatment of transthyretin (ATTR) amyloidosis using in vivo gene editing technology

Scientific research in the nature of conducting clinical trials for the treatment of transthyretin (ATTR) amyloidosis using in vivo gene editing technology

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 28, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 28, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
Dec 17, 2024 EX1G
SOU EXTENSION 1 FILED
Dec 16, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 16, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 25, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 30, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 10, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 22, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 23, 2024 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Dec 23, 2023 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Dec 23, 2023 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Dec 23, 2023 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Dec 23, 2023 CPEA
ASSIGNED TO EXAMINER
Dec 7, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 30, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 29, 2023 NWOS
NEW APPLICATION ENTERED
Mar 13, 2023 NWAP